Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 3 results for "nirmal bang institutional equities"

It wouldn#39;t be wise to change Biocon#39;s EPS estimate with...

In an interview to CNBC-TV18, Vishal Manchanda, Pharma Analyst at Nirmal Bang Institutional Equities shared his views and readings on the news as well as on Biocon stock. Money Control, 2 months ago
Here are Rahul Arora#39;s views on market stocks Money Control, 2 months ago

A tough quarter but outlook positive for IT services firms

Mini Tejaswi City: Bangalore Days before TCS kicks off the Q2 results calendar, the overall outlook for the IT industry remains positive though muted across key geographies and verticals The last quarter, that is Q2 of the fiscal, was a tough period for most ...
 The Financial Chronicle2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less